VDI-TKcanine+, a blood test to detect and monitor cancer in dogs

VDI-TKcanine+, a blood test to detect and monitor cancer in dogs, is awarded the Seal of Excellence by the National Canine Cancer Foundation

THIS SOUNDS INTERESTING IF IT WORKS! I TALKED TO THEM AND IT SOUNDS GOOD. SEND THIS TO YOUR VET. THIS IS A GREAT ALTERNATIVE TO SPENDING HUGE $$$$ AND LESS INVASIVE.

Phoenix, AZ - (BUSINESS WIRE) - July 25, 2012 - The National Canine Cancer Foundation (NCCF), a non-profit organization dedicated to eliminating canine cancer,  today announced the awarding of its ‘Seal of Excellence' to VDI-TKcanine+, a blood test to detect and monitor cancer in dogs, and offered exclusively by Veterinary Diagnostics Institute (VDI). Cancer affects one out of every three dogs with half dying from the disease. "One of the keys to saving lives and beating cancer is early detection, and now with VDI-TKcanine+, every dog owner has access to a simple blood test for this very purpose.", said Gary Nice, Founder and President of the NCCF. "Since the day we founded the NCCF, I've been waiting to make this announcement." VDI-TKcanine+ is a rapid turnaround send-out blood test made available to dog owners across the U.S. through their veterinarians. The blood test is used to confirm the presence of disease when cancer is suspected, and to monitor the course of treatment or spread of disease following diagnosis.  "There is a strict criteria used in awarding the Seal of Excellence by the NCCF.", explains Gary Nice. "In fact, this is only the second product and company to receive our coveted award". "We are very proud to be partnering with the NCCF to help fund canine cancer research.", said Randy Ringold, President of VDI.  "The goals of the NCCF to find cures, better treatments and cost-effective diagnostics in managing canine cancer very much align with our own." About The National Canine Cancer Foundation The National Canine Cancer Foundation is a nationwide, contribution funded, 501 (c)(3) non-profit corporation dedicated to eliminating cancer as a major health issue in dogs by funding grants directly to cancer researchers who are working to save dogs lives by finding cures, better treatments and accurate, cost effective diagnostic methods in dealing with canine cancer. About Veterinary Diagnostics Institute Veterinary Diagnostics Institute (VDI) is a specialty diagnostics company that provides veterinary reference laboratory services and in-house diagnostic products. VDI is dedicated to the research and development of innovative biomarkers to assist veterinarians in the diagnostic workup of companion animals. Dual Biomarker Test Design VDI-TKcanine+ combines the information obtained from two independent measures of system irregularity; abnormal cell division and systemic inflammatory activity. Thymidine kinase (TK) is a measure of dysregulated cellular proliferation. C-reactive protein (CRP) is elevated in the presence of systemic inflammatory disease. Neoplasia Index The Neoplasia Index (NI) is a patent-pending, dual-biomarker algorithm that employs cancer specific TK and general inflammatory marker CRP.  The integration of these two biomarkers into a “neoplasia index” brings two unrelated processes together (namely dysregulated cell division and systemic inflammation, for which cancer is one possible cause of that inflammation) and effectively amplifies the situation whereby the two may be elevated in concert (i.e. neoplasia). VDI (805) 577-6742 http://www.vdilab.com/page.php?id=60 details on how it works Vets link to order labs http://www.vdilab.com/page.php?id=61

Lucy Nasal Cancer Status 2 years 5 months after biopsy

Still Ok.

Cancer Hopes Dashed by Myopic Researchers

"Researchers still continue to pursue the idea of finding the one chemical that will halt or reverse the disease when it’s obvious that so many things are wrong that the approach will never work."